The Ohio State University Asthma Registry

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by Ohio State University
Sponsor:
Information provided by (Responsible Party):
John Mastronarde, MD, Ohio State University
ClinicalTrials.gov Identifier:
NCT00839748
First received: February 6, 2009
Last updated: November 18, 2013
Last verified: November 2013
  Purpose

The purpose of this study is to collect information in order to identify people who have asthma and who may be good candidates to participate in one of the future asthma studies to be conducted at The Ohio State University Asthma Clinical Research Center.


Condition
Asthma

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Ohio State University Asthma Registry

Resource links provided by NLM:


Further study details as provided by Ohio State University:

Primary Outcome Measures:
  • an asthmatic agrees to have their name and information put in the registry will help study staff determine the most likely candidates for each study [ Time Frame: end of study ] [ Designated as safety issue: No ]

Estimated Enrollment: 500
Study Start Date: February 2004
Estimated Study Completion Date: June 2014
Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
asthmatics
asthmatics registry for those interested in future asthma studies

Detailed Description:

Patients from The Ohio State University Division of Pulmonary and Critical Care Medicine will be sent a letter explaining the registry and asking about their interest in participating in this registry. The registry and all procedures related to their inclusion will be explained, opportunity to ask questions will be given and a consent document signed prior to any registry activity. Information about the registry will be shared with the community by newspaper ads, Internet postings, word of mouth, flyers, and other pulmonologists in central Ohio. Those potential registrants may choose to make an appointment to complete lung function tests at the Asthma Clinical Research Center.

The registry and all procedures related to their inclusion will be explained, opportunity to ask questions will be given and a consent document signed prior to any registry activity.

Each participant will be asked to provide appropriate (general medical history, asthma history, current medications, past asthma medications, demographic information, weight height, smoking history, allergies, and prior surgeries. Participants will be asked to complete an Asthma Control Questionnaire, which will be scored to determine how well their asthma is controlled. All consented registrants will be given the opportunity to visit The Ohio State University Asthma Clinical Research Center where an extensive lung function test (spirometry) will be provided. At the Asthma Clinical Research Center each registrant will perform at least three lung function efforts, then given two puffs of albuterol (a fast acting medication that opens airways). After a standard waiting period that meets the standards of the American Thoracic Society, a second set of lung function test will be done. The results of the second set of tests will reflect any reversibility in lung function levels, and will serve as an indicator that treatment may improve lung function. All participants will be given copies of all lung function tests, and the results of the test will be explained to them. All study procedures are provided without cost to the registrant.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

primary care clinic, community sample

Criteria

Inclusion Criteria:

  • asthma
  • must be able to provide medical history

Exclusion Criteria:

  • unable to give consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00839748

Contacts
Contact: Pulmonary Clinical Trials Office 614-293-4978 Lung.Research@osumc.edu
Contact: Catherine Balint 614-366-2761 Catherine.Balint@osumc.edu

Locations
United States, Ohio
The Ohio State University Recruiting
Columbus, Ohio, United States, 43210
Principal Investigator: John G Mastronarde, MD         
Sponsors and Collaborators
Ohio State University
Investigators
Principal Investigator: John G Mastronarde, MD Ohio State University
  More Information

No publications provided

Responsible Party: John Mastronarde, MD, Professor of medicine, Ohio State University
ClinicalTrials.gov Identifier: NCT00839748     History of Changes
Other Study ID Numbers: 2003H0221
Study First Received: February 6, 2009
Last Updated: November 18, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Ohio State University:
asthma
registry for future asthmatic studies
questionnaires
lung function tests

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on July 26, 2014